Tekla Capital Management LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$18,990,000
+7.8%
223,336
-55.1%
0.71%
+6.1%
Q2 2020$17,617,000
+168.3%
497,103
+2.1%
0.67%
+125.9%
Q1 2020$6,566,000
-36.3%
487,1030.0%0.30%
-23.8%
Q4 2019$10,307,000
+59.6%
487,1030.0%0.39%
+38.3%
Q3 2019$6,459,000
+19.6%
487,103
+25.1%
0.28%
+28.2%
Q2 2019$5,400,000
-2.3%
389,313
+35.3%
0.22%
-1.8%
Q1 2019$5,526,000
-10.3%
287,687
-33.3%
0.22%
-15.2%
Q4 2018$6,158,000
+203.6%
431,527
+343.2%
0.26%
+256.8%
Q3 2018$2,028,000
+5.9%
97,370
-80.5%
0.07%
-2.6%
Q1 2015$1,915,000500,0000.08%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders